A Synthetic Binder of Breast Cancer Stem Cells

Chemistry. 2018 Mar 12;24(15):3694-3698. doi: 10.1002/chem.201705663. Epub 2018 Feb 19.

Abstract

Cancer stem cells (CSCs) are associated with drug resistance, metastasis and recurrence of cancer. A synthetic binder of CSCs can provide a valuable tool to study the biology of CSCs and a lead to develop imaging, diagnostic and therapeutic agents targeting CSCs. Herein, a synthetic ligand (1) that specifically binds to CSCs over non-CSCs of breast cancer cells was identified for the first time via a cell-binding screening of a chemical library. The ligand 1 showed specific binding to CD24- /CD44+ /ALDH+ CSC population of MCF-7 and MDA-MB-231. We have demonstrated that 1-immobilized beads can be used as matrices for affinity isolation of 1-binding CSC population from breast cancer cells. The 1-binding population showed significantly increased expressions of stemness-associated transcription factors. Importantly, the 1-binding population demonstrated accelerated tumor growth in vivo, and the resulting tumor displayed an increased migratory activity and high expressions of CSC markers.

Keywords: biological chemistry; cancer; high-throughput screening; stem cells; tumors.

MeSH terms

  • Breast Neoplasms / drug therapy*
  • Cell Line, Tumor
  • Cell Proliferation / drug effects
  • Drug Resistance, Neoplasm
  • Female
  • Humans
  • Hyaluronan Receptors / metabolism
  • MCF-7 Cells
  • Neoplastic Stem Cells / metabolism*

Substances

  • CD44 protein, human
  • Hyaluronan Receptors